Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007306 |
---|---|
Receipt number | R000008210 |
Scientific Title | Optimal period of adjuvant S-1 chemotherapy for pathological stage II gastric cancer patients who underwent D2 gastrectomy(JCOG1104) |
Date of disclosure of the study information | 2012/02/16 |
Last modified on | 2022/08/30 16:22:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/02/16 13:56:13 | ||
2 | Update | 2012/02/16 14:02:17 | Date of disclosure of the study information |
|
3 | Update | 2012/05/24 15:39:42 | Institutions |
|
4 | Update | 2012/06/20 11:33:58 | Acronym Acronym |
|
5 | Update | 2013/05/22 16:21:15 | Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
6 | Update | 2014/10/15 15:55:45 | Key inclusion criteria Key inclusion criteria |
|
7 | Update | 2014/10/15 15:58:24 | TEL Address Address TEL Institutions |
|
8 | Update | 2014/10/15 15:58:59 | Anticipated trial start date Last follow-up date |
|
9 | Update | 2016/12/07 15:39:03 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
10 | Update | 2016/12/07 15:41:16 | Name of primary person or sponsor Organization Institutions |
|
11 | Update | 2016/12/07 15:42:05 | Last follow-up date |
|
12 | Update | 2017/03/22 11:48:14 | Recruitment status |
|
13 | Update | 2022/08/30 15:53:41 | Recruitment status Date of IRB |
|
14 | Update | 2022/08/30 16:22:30 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled |